@MWG_Jamie@compoundpapi And you forgot to mention they took out all the convertible debt last year and refinanced the whole lot with high-yield AT LOWER RATES than the dilutive paper.
@Larryjamieson_ Not an adult company. Last q, they had an FX gain of $7M, it was not removed from adjusted EPS or EBITDA. This recent Q, there was a FX loss of $6.5M, and you better believe it was fully adjusted back. What even is that?
@AutismCapital 🤔
On offshore platforms, a magenta alarm typically signifies a high- priority danger or a particularly hazardous situation requiring immediate action, such as an area with high levels of combustible gas.
Viridian Therapeutics shares rise as much as 3.5% after the drug developer said the FDA granted its biologics license application for an eye-disease treatment, a shorter priority review
When $VKTX turn?
@bioinvestor24 What would cause this on Sept 3rd? "solely to an unanticipated recent internal development that made it impossible for Party 2 to enter into a transaction in which it would agree to issue Party 2 stock, Party 2 would not be able to continue to pursue an acquisition of Metsera."
I'm sorry, if $ETBN is work $3.5B, there is NO WAY $VKTX is worth less. They have a MASH drug, and they're not focusing on it because it's their 3rd best drug!
They basically run a platform for appraisers in the US. They've cut costs to the bone as it's been lean with no refi activity. Once rates get 50bps below your rate (in US obviously), it's refinancing time. We're falling below that for the last 2 years of mortgages
https://t.co/ITeqz7gdUP